ProShares UltraShort NASDAQ Biotechnology
BIS
ProShares UltraShort NASDAQ Biotechnology (BIS) news
Recent news
Nasdaq Inc: TD Cowen cuts target price to $107 from $108
TD Cowen has revised its target price for Nasdaq Inc, lowering it to $107 from the previous $108, according to the firm’s latest strategy update . The adjustment reflects a reassessment of the company’s near-term outlook and market conditions. While the change is relatively modest, it signals a…
AInvest Wire · 3d agoImportantUS Commerce Department BIS updates Cuba export controls
AInvest Wire · Mar 4, 2026ImportantBIS suspends Cuba license use for funds entering Cuban banks
AInvest Wire · Mar 4, 2026ImportantU.S. Commerce Department: Applied Materials will pay $252 million penalty to BIS for illegal semiconductor equipment exports
AInvest Wire · Feb 12, 2026Turkey's main BIST 100 index up 1.18%, banking index up 2%
AInvest Wire · May 16, 2025Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.